PFS Investments’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $3.31M | Sell |
15,739
-211
| -1% | -$44.4K | 0.05% | 273 |
|
|
2023
Q1 | $3.14M | Buy |
15,950
+63
| +0.4% | +$12.4K | 0.05% | 265 |
|
|
2022
Q4 | $3.46M | Sell |
15,887
-606
| -4% | -$132K | 0.06% | 233 |
|
|
2022
Q3 | $3.25K | Buy |
16,493
+2,490
| +18% | +$490 | 0.06% | 222 |
|
|
2022
Q2 | $3M | Buy |
14,003
+2,418
| +21% | +$517K | 0.06% | 241 |
|
|
2022
Q1 | $3.29M | Buy |
11,585
+2,876
| +33% | +$817K | 0.06% | 235 |
|
|
2021
Q4 | $3.28M | Buy |
+8,709
| New | +$3.28M | 0.06% | 233 |
|